{"SPADE_UN_10172": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7556813 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7556813_B2", "Patent Type": "Granted Patent", "Publication Date": "2009-7-7", "Family Info": "CA2497767A1,CN1684972A,EP1554306A2,EP1554306A4,US20040122214,US20100016225,WO2004029073A2,WO2004029073A3", "Patent Title": "Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides.", "Abstract": "Provided are conjugates comprising a polymer having operably bound thereto no less than two molecules of synthetic peptide derived from HIV gp41; methods of using these conjugates to inhibit transmission of HIV to a target cell by adding an amount of effective to inhibit infection of the cell by the virus; and methods of producing the conjugates by operably binding each molecule of synthetic peptide, via a reactive functionality, to the polymer."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10172", "Sequence": "WQEWDREITALLEQAQIQQEKNEYELQKLDEWASLWEWF", "Sequence Length": 39, "Peptide Name": "Sequence 52 from Patent US 7556813", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "EQL", "Absent Amino Acids": "CGHMOPUV", "Basic Residues": 3, "Acidic Residues": 10, "Hydrophobic Residues": 17, "Polar Residues": 16, "Positive Residues": 3, "Negative Residues": 10, "Mass": 5011.42, "PI": 4.05, "Net Charge": -7, "Hydrophobicity": -1.1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_10169", "Similarity": 1.0, "Sequence": "WQEWDREISNYTSLITALLEQAQIQQEKNEYELQKLDEWASLWEWF"}, {"SPADE_ID": "SPADE_UN_10173", "Similarity": 1.0, "Sequence": "WQEWDREITALLEQAQIQQEKNEYELQKLDEWEWF"}, {"SPADE_ID": "SPADE_UN_10171", "Similarity": 0.9487179487179487, "Sequence": "WQEWDREITALLEQAQIQQEKNEYELQKLDKWASLWNWF"}]}}}